Related Experiment Video

Updated: Sep 11, 2025

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
15:33

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation

Published on: August 13, 2013

16.0K

The Streptomyces Metabolite Thiostrepton Inhibits Regulatory T Cell Differentiation and Function to Boost Antitumor

Luana Silva1, Luís Almeida1, Fatima Al-Naimi1

  • 1Institute of Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.

European Journal of Immunology
|August 18, 2025
PubMed

Insights

The antibiotic thiostrepton effectively inhibits regulatory T cells (Tregs), a key barrier in cancer immunotherapy. This discovery offers a new strategy to enhance antitumor immune responses and improve cancer treatment outcomes.

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Regulatory T cells (Tregs) promote tumor progression and reduce cancer therapy effectiveness.
  • Targeting Tregs is crucial for advancing cancer immunotherapy.
  • Currently, no in vivo tools exist to inhibit Treg function or differentiation.

Purpose of the Study:

  • To investigate the potential of the antibiotic thiostrepton as an inhibitor of regulatory T cells (Tregs).
  • To determine if thiostrepton can overcome Treg-mediated immunosuppression in a tumor microenvironment.

Main Methods:

  • In vitro and in vivo studies using mouse models (MC38 tumor model).
  • Assessment of thiostrepton's effects on Treg differentiation, activation markers, and suppressive functions.
  • Analysis of intratumoral Treg cell populations and tumor growth.

Main Results:

  • Thiostrepton significantly inhibits Treg differentiation and function.
  • Thiostrepton reduces the number of intratumoral Foxp3+ Treg cells in a tumor model.
  • Thiostrepton treatment prevents tumor growth in mice.
  • Effects were conserved in human T cells, inhibiting human Treg differentiation.

Conclusions:

  • Thiostrepton demonstrates potent inhibitory effects on both mouse and human Tregs.
  • Thiostrepton represents a novel immunomodulatory compound for Treg-targeted cancer therapy.
  • This antibiotic has the potential to enhance antitumor immune responses and improve immunotherapy efficacy.
Keywords:
T cellsimmune responsesimmunotherapyregulatory T cellstumor immunology

More Related Videos

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants10:44

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

Published on: August 9, 2019

7.3K
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

14.8K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
4.6K